Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/3/2026

Revised Cardiac Risk Index (RCRI) for Non‑Cardiac Surgery

Scope and Validation

  • The Revised Cardiac Risk Index (RCRI) is specifically designed and validated for predicting peri‑operative cardiac complications in patients undergoing non‑cardiac surgery; it is not applicable to cardiac surgery. 1
  • RCRI is the most extensively validated clinical risk index for estimating peri‑operative cardiac risk in the non‑cardiac surgical population. 4

Indications (Guideline Society Recommendation)

  • The Canadian Cardiovascular Society recommends using the RCRI for pre‑operative cardiac risk assessment in patients ≥ 45 years old (or 18‑44 years old with known significant cardiovascular disease) who are scheduled for elective non‑cardiac surgery. 5

Six RCRI Risk Factors (each assigned 1 point)

  • Ischemic heart disease (history of myocardial infarction, positive stress test, chest pain requiring nitrates, or pathological Q‑waves on ECG). 3
  • Congestive heart failure (clinical signs such as pulmonary edema, paroxysmal nocturnal dyspnea, S3 gallop, bilateral rales, or radiographic evidence of pulmonary vascular redistribution). 6
  • Cerebrovascular disease (history of stroke or transient ischemic attack). 3
  • Insulin‑treated diabetes (pre‑operative insulin therapy). 6
  • Renal impairment (pre‑operative serum creatinine > 177 µmol/L ≈ 2.0 mg/dL). 4
  • High‑risk surgery (procedures classified as intraperitoneal, intrathoracic, or supra‑inguinal vascular surgery). 3

Risk Stratification for 30‑Day Cardiac Events

RCRI Score 30‑Day Event Risk 95 % Confidence Interval
0 points 3.9 % 2.8 % – 5.4 %
1 point 6.0 % 4.9 % – 7.4 %
2 points 10.1 % 8.1 % – 12.6 %
≥ 3 points 15.0 % 11.1 % – 20.0 %

[All values from external validation cohort] [7]

  • Between 2008 and 2013, the proportion of surgical inpatients classified as high cardiovascular risk (RCRI ≥ 3) rose from 6.6 % to 7.7 %, as reported in the 2024 AHA/ACC guidelines. 9
  • Canadian guidelines favor the RCRI over newer indices such as NSQIP‑MICA because those newer studies lacked systematic troponin monitoring and likely underestimated cardiac risk. 11

Derivation Population

  • The RCRI was derived and validated exclusively in non‑cardiac surgical populations, confirming its inapplicability to cardiac surgery where different risk models (e.g., STS score, EuroSCORE) are required. 12

REFERENCES